AtonRa Partners’s Burning Rock Biotech BNR Stock Holding History

AtonRa Partners’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,670	Closed	-$341K	–	126
2022 Q1	$341K	Sell	3,670 -614	-14%	-$53.3K	0.19%	109
2021 Q4	$408K	Buy	4,284 +214	+5%	+$29.3K	0.14%	112
2021 Q3	$728K	Buy	4,070 +526	+15%	+$117K	0.24%	108
2021 Q2	$1.04M	Sell	3,544 -21	-0.6%	-$6.21K	0.38%	92
2021 Q1	$960K	Buy	+3,565	New	+$1.09M	0.43%	89

Other funds holding BNR

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AtonRa Partners's BNR Position: Q2 2022 in Review

AtonRa Partners sold out of Burning Rock Biotech (BNR) in Q2 2022, closing a stake of 3,670 shares — an estimated $341K sold.

AtonRa Partners first reported a position in BNR in Q1 2021 and held it in 5 quarters. The position peaked at $1.04M in Q2 2021. 50 funds tracked by Wall St. Rank hold BNR as of Q2 2022.

AtonRa Partners reported no remaining Burning Rock Biotech position as of Q2 2022 after selling out during the quarter.
AtonRa Partners sold 3,670 Burning Rock Biotech shares in Q2 2022, an estimated $341K.
AtonRa Partners first reported a position in Burning Rock Biotech in Q1 2021 and held it in 5 quarters.
AtonRa Partners's Burning Rock Biotech position peaked at $1.04M in Q2 2021.
50 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2022.

Based on AtonRa Partners's 13F filing for Q2 2022, filed 15 Aug 2022.